U.S. Federal Drug Administration has approved a drug for human that was produced in a genetically engineered plant cell. This approval could lead to sanction of several GMO drugs. The drug called Elelyso, is a treatment for a disorder known as Gaucher disease that results from the lack of a specific enzyme. The ability to manipulate the genes of plant cells to produce certain human enzymes is not new, plant-derived biologic treatments have proven successful in drugs given to animals in recent years. However, for the first time FDA approved the medicine for the human use. Now that plant-derived human biologics have a foot in the door with the FDA, researchers think they can create enzymes to treat a variety of disorders using bio-pharma techniques.
If you want to "Be GMO Free" stay informed by checking out these recommended books featured on GeneticallyEngineeredFoodNews.com!